Aurisco Pharmaceutical Co.,Ltd.(XSSC:605116) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 CNY | -3.65% |
|
+2.64% | -14.18% |
25/06 | Aurisco Pharmaceutical Gets Approval for Convertible Bond Sale | MT |
28/04 | Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.18% | 1.29B | |
+55.19% | 801B | |
+47.26% | 631B | |
-6.09% | 359B | |
+21.92% | 337B | |
+18.40% | 245B | |
+3.64% | 231B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 161B |
- Stock Market
- Equities
- 605116 Stock
- News Aurisco Pharmaceutical Co.,Ltd.
- Aurisco Pharmaceutical Co.,Ltd.(XSSC: 605116) added to S&P Global BMI Index